<DOC>
	<DOCNO>NCT00008853</DOCNO>
	<brief_summary>The purpose study test safety favorable immune response anti-streptococcal vaccine ( vaccine treat common bacterial infection ) healthy non-pregnant woman . Group B Streptococcus ( GBS ) continue single frequent cause life-threatening bacterial infection first 2 month life . Further , GBS pregnancy-related morbidity afflict 50,000 woman annually US . Therefore , active immunization woman appeal strategy prevention GBS disease pregnant woman infant first 3 month infant life .</brief_summary>
	<brief_title>Evaluation Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines</brief_title>
	<detailed_description>In study 65 healthy , non-pregnant woman receive single dose one two anti-streptococcal vaccination . Both types vaccination give upper arm injection muscle . To assess vaccine effectiveness , patient blood draw examined week 4 , 8 26 , post-vaccination .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<criteria>This information currently available .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Clinical Evaluation</keyword>
</DOC>